Treating multiple myeloma with high-level dose chemotherapy supported by transplanted autologous stem cells is still the primary and appropriate therapeutic strategy in affected patients. Today, although the responses have improved considerably, especially during the treatment with the induction of the combination of immunomodulatory medication and proteasome blockers, no treatment approach has taken autologous stem cell transplantation into the background. In this review, we will share the recent place of autologous stem cell transplantation in myeloma will be discussed from pretransplant treatment to posttransplant.
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Review Articles |
Authors | |
Early Pub Date | October 6, 2023 |
Publication Date | September 30, 2023 |
Submission Date | February 11, 2023 |
Acceptance Date | March 21, 2023 |
Published in Issue | Year 2023 Volume: 40 Issue: 3 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.